Doença hepática associada à cirurgia de Fontan · Nódulos hepáticos · Carcinoma hepatocelular · Hiperplasia nodular focal múltipla ·

A 22-year-old female, who had underwent Fontan procedure in childhood, presented with mild elevation of liver enzymes (AST 35 U/L, ALT 50 U/L, ALP 62 U/L, GGT 61 U/L). She had no liver dysfunction (total bilirubin 1.3 mg/dL, INR 1.1, albumin 3.7 g/dL), signs of cirrhosis or portal hypertension (platelets 177 × 109), encephalopathy or ascites.

Viral, autoimmune, metabolic, and toxic etiologies were excluded. Abdominal ultrasound showed a diffusely heterogeneous and micronodular liver parenchyma, compatible with Fontan-associated liver disease (FALD) in this context. Moreover, multiple de novo hyperechogenic nodules were found, imposing investigation.

MRI reported >12 nodules, maximum diameter of 27 mm, isointense in T1-weighted sequences, hypointense in T2, with no restricted diffusion (shown in Fig. 1). Some were halo-surrounded, while others displayed a central scar. Most displayed hyper-enhancement in the hepatic arterial phase (shown in Fig. 2), becoming isointense in the portal phase and hypointense in the delayed one, a worrisome feature known as washout (shown in Fig. 3). Using hepatobiliary contrast, all nodules showed hyperintensity (shown in Fig. 4). Bloodwork revealed normal alpha-fetoprotein (AFP). Therefore, the final diagnosis of multiple focal nodular hyperplasia (FNH)-like in a FALD background was made, and the patient kept under surveillance.

Multiple de novo liver nodules are seen (arrows).

Hepatic arterial phase shows enhancement of nodule in segment V (arrow).

Late phase shows washout in the same nodule (arrow).

Hepatobiliary phase shows hyperintensity of nodule in segment VI (arrow).

The Fontan procedure is a palliative surgery for patients with an anatomic or functional single-ventricular congenital heart disease, consisting of a total extracardiac cavopulmonary connection created by anastomosing the superior vena cava to the right pulmonary artery (PA) and insertion of an extracardiac conduit between the inferior vena cava and the PA [1, 2]. The consequent chronic liver congestion and ischemia result in FALD, leading to cirrhosis in 1–5% of patients per year and hepatocellular carcinoma (HCC) in 1.3% [1-3]. Indeed, annual and early liver surveillance is mandatory [1].

Multiple FNH is a rare entity which has been associated with some vascular diseases and treatments [4, 5]. This clinical case highlights an association between multiple FNH and FALD. Given the inherent risk of HCC in FALD and similar MRI findings between FNH and HCC in this background, their differential diagnosis becomes challenging [1, 2]. In this context, AFP and MRI hepatobiliary contrast are key [2, 3]. Nonetheless, biopsy should be considered in dubious and atypical nodules [1].

The study did not require ethics approval. Informed consent was obtained from the patient for publication of this case report and any accompanying images.

The authors have no conflicts of interest to declare.

There are no funding sources to declare.

All authors participated in the design, construction, and revision of the paper.

All data generated or analyzed during this study are included in this article.

This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.